Breaking News Instant updates and real-time market news.

GLYC

GlycoMimetics

$12.62

-0.17 (-1.33%)

13:45
07/16/19
07/16
13:45
07/16/19
13:45

GlycoMimetics call volume above normal and directionally bullish

Bullish option flow detected in GlycoMimetics with 2,072 calls trading, 3x expected, and implied vol increasing almost 15 points to 180.78%. Aug-19 17.5 calls and Aug-19 20 calls are the most active options, with total volume in those strikes near 1,800 contracts. The Put/Call Ratio is 0.11. Earnings are expected on August 8th.

  • 23

    Jul

  • 09

    Sep

GLYC GlycoMimetics
$12.62

-0.17 (-1.33%)

05/13/19
PIPR
05/13/19
NO CHANGE
PIPR
Piper 'incrementally more bullish' on GlycoMimetics, Global Blood
After speaking to a practicing hematologist and emergency medicine doctor at a leading medical institution, Piper Jaffray analyst Danielle Brill is "incrementally more bullish" on both GlycoMimetics (GLYC) and Global Blood Therapeutics (GBT). The former has pivotal Phase 3 data with rivipansel expected in July and the latter is in the process of submitting a new drug application for voxelotor via the accelerated approval pathway, Brill tells investors in a research note. Further, the analyst says feedback from the expert reaffirmed her neutral outlook for Bluebird Bio's (BLUE) LentiGlobin. The hematologist expects rivipansel to be successful in the Phase 3 trial and anticipates use for most acute sickle cell disease crises requiring provider intervention, according to Brill. Further, she was surprised to hear how enthusiastic the expert was about voxelotor.
05/28/19
PIPR
05/28/19
NO CHANGE
PIPR
Piper more bullish on GlycoMimetics, Global Blood into upcoming catalysts
After surveying 25 sickle cell disease experts, Piper Jaffray analyst Danielle Brill is "incrementally more bullish" on both GlycoMimetics (GLYC) and Global Blood Therapeutics (GBT) into their upcoming catalysts. GlycoMimetics and partner Pfizer (PFE) have pivotal Phase 3 results with rivipansel, their pan-selectin inhibitor, reading out in July, Brill tells investors in a research note. And Global Blood Therapeutics is expected to complete its new drug application submission for voxelotor via the accelerated approval pathway and present full Phase 3 Hope trial data in June, adds the analyst. Following expert feedback, Brill remains confident for a successful Phase 3 outcome with rivipansel. She believes positive data will drive GlycoMimetics shares "meaningfully higher" in July. Further, the majority of the surveyed doctors believe voxelotor's hemolytic anemia benefit is clinically relevant and most expect accelerated approval based on these data, adds the analyst.
06/28/19
JEFF
06/28/19
NO CHANGE
Target $19
JEFF
Buy
GlycoMimetics shares could rally 50% on rivipansel data, says Jefferies
Pfizer (PFE) is expecting data from Phase 3 testing of rivipansel, a treatment for sickle cell patients experiencing vaso-occlusive crises, in the July/August timeframe, Jefferies analyst Biren Amin tells investors in a research note. Given that GlycoMimetics (GLYC) would receive royalties on worldwide sales, the stock may move 50% on positive data and drop 40% on a negative outcome, says the analyst. He believes that while the trial is difficult to predict, the design and the enrollment of younger patients "provide some confidence of a positive outcome." Amin keeps a Buy rating on GlycoMimetics shares with a $19 price target.
07/12/19
PIPR
07/12/19
NO CHANGE
Target $20
PIPR
Overweight
GlycoMimetics risk/reward 'highly favorable' into data, says Piper Jaffray
Piper Jaffray analyst Danielle Brill thinks there is a "substantial amount of evidence" that shows clear proof-of-efficacy of GlycoMimetics' rivipansel in the sickle cell disease population. As such, the analyst remains confident that the Phase 3 data expected this quarter will be positive. The stock's risk/reward is "highly favorable," with 70%-100% upside versus downside of 20%-25% on the readout, making GlycoMimetics "even more compelling ahead of the data," Brill tells investors in a research note. She reiterates an Overweight rating on the shares with a $20 price target.

TODAY'S FREE FLY STORIES

ARMK

Aramark

$40.98

3.91 (10.55%)

10:27
08/19/19
08/19
10:27
08/19/19
10:27
Recommendations
Aramark analyst commentary  »

Aramark price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SFDL

Security Federal Corp

$0.00

(0.00%)

10:25
08/19/19
08/19
10:25
08/19/19
10:25
Hot Stocks
Security Federal Corp raises quarterly dividend to 10c per share »

Security Federal…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CGC

Canopy Growth

$26.74

-1.36 (-4.84%)

10:25
08/19/19
08/19
10:25
08/19/19
10:25
Options
Canopy Growth call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CNMD

Conmed

$95.93

0.93 (0.98%)

10:25
08/19/19
08/19
10:25
08/19/19
10:25
Conference/Events
Conmed participates in a conference call with SVB Leerink »

SVB Leerink hosts a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Aug

  • 09

    Sep

ATEC

Alphatec

$6.07

0.08 (1.34%)

10:21
08/19/19
08/19
10:21
08/19/19
10:21
Hot Stocks
Alphatec granted 510(k) premarket notification for Lateral Interbody System »

The FDA judged the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Sep

PRAH

PRA Health

$97.99

0.87 (0.90%)

10:19
08/19/19
08/19
10:19
08/19/19
10:19
Hot Stocks
PRA Health announces strategic alliance between Symphony Health and Close-Up »

PRA Health Sciences…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

10:17
08/19/19
08/19
10:17
08/19/19
10:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

10:16
08/19/19
08/19
10:16
08/19/19
10:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SHAK

Shake Shack

$95.89

-1.17 (-1.21%)

10:15
08/19/19
08/19
10:15
08/19/19
10:15
Options
Shake Shack put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:13
08/19/19
08/19
10:13
08/19/19
10:13
General news
E-Commerce Retail Sales E- Q/Q Change SAAR data reported »

E-Commerce Retail Sales…

NXPI

NXP Semiconductors

$103.80

0.25 (0.24%)

, AMD

AMD

$31.81

0.63 (2.02%)

10:12
08/19/19
08/19
10:12
08/19/19
10:12
Initiation
Fly Intel: Top five analyst initiations »

Catch up on today's…

NXPI

NXP Semiconductors

$103.80

0.25 (0.24%)

AMD

AMD

$31.81

0.63 (2.02%)

NOVA

Sunnova Energy

$11.73

0.69 (6.25%)

XOM

Exxon Mobil

$69.14

0.84 (1.23%)

CVX

Chevron

$117.20

1.41 (1.22%)

COP

ConocoPhillips

$52.92

1.46 (2.84%)

OXY

Occidental Petroleum

$45.15

0.5 (1.12%)

HES

Hess Corp.

$61.42

1.61 (2.69%)

CSTL

Castle Biosciences

$20.77

0.63 (3.13%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Aug

  • 19

    Aug

  • 20

    Aug

  • 27

    Aug

  • 27

    Aug

  • 10

    Sep

APD

Air Products

$228.62

-0.15 (-0.07%)

, WLL

Whiting Petroleum

$8.65

0.04 (0.46%)

10:12
08/19/19
08/19
10:12
08/19/19
10:12
Downgrade
Fly Intel: Top five analyst downgrades »

Catch up on today's…

APD

Air Products

$228.62

-0.15 (-0.07%)

WLL

Whiting Petroleum

$8.65

0.04 (0.46%)

CELG

Celgene

$95.15

0.45 (0.48%)

AMGN

Amgen

$204.27

0.32 (0.16%)

ARLP

Alliance Resource Partners

$15.10

0.15 (1.00%)

BTU

Peabody Energy

$19.15

-0.03 (-0.16%)

TRIL

Trillium Therapeutics

$0.29

0.0097 (3.52%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Aug

  • 27

    Aug

  • 03

    Sep

  • 03

    Sep

  • 09

    Sep

  • 16

    Sep

  • 19

    Sep

  • 23

    Sep

  • 08

    Oct

  • 09

    Oct

  • 04

    Dec

  • 25

    Mar

  • 04

    Apr

DECK

Deckers Brands

$138.02

3.69 (2.75%)

, SONO

Sonos

$12.75

0.85 (7.14%)

10:12
08/19/19
08/19
10:12
08/19/19
10:12
Upgrade
Fly Intel: Top five analyst upgrades »

Catch up on today's…

DECK

Deckers Brands

$138.02

3.69 (2.75%)

SONO

Sonos

$12.75

0.85 (7.14%)

ARMK

Aramark

$40.50

3.43 (9.25%)

ACM

Aecom

$34.02

1.05 (3.18%)

ON

ON Semiconductor

$18.20

0.645 (3.68%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Sep

  • 13

    Sep

  • 23

    Sep

  • 25

    Sep

LYFT

Lyft

$52.22

-0.15 (-0.29%)

, GOOG

Alphabet

$1,197.73

20.79 (1.77%)

10:05
08/19/19
08/19
10:05
08/19/19
10:05
On The Fly
Lyft rises as lock-up period following IPO ends »

Shares of Lyft (LYFT) are…

LYFT

Lyft

$52.22

-0.15 (-0.29%)

GOOG

Alphabet

$1,197.73

20.79 (1.77%)

GOOGL

Alphabet Class A

$1,199.00

20.31 (1.72%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Sep

  • 24

    Sep

  • 27

    Oct

SE

Sea Limited

$36.60

1.17 (3.30%)

10:05
08/19/19
08/19
10:05
08/19/19
10:05
Options
Sea Limited call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Aug

BMA

Banco Macro

$35.45

-2.83 (-7.39%)

10:00
08/19/19
08/19
10:00
08/19/19
10:00
Hot Stocks
Banco Macro falls -7.4% »

Banco Macro is down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JNUG

Direxion Daily Jr Gld Mnrs Bull 3X Shrs

$71.80

-6.28 (-8.04%)

10:00
08/19/19
08/19
10:00
08/19/19
10:00
Hot Stocks
Direxion Daily Jr Gld Mnrs Bull 3X Shrs falls -8.2% »

Direxion Daily Jr Gld…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PCG

PG&E

$10.80

-3.5 (-24.48%)

10:00
08/19/19
08/19
10:00
08/19/19
10:00
Hot Stocks
PG&E falls -24.4% »

PG&E is down -24.4%,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UNT

Unit Corp.

$3.58

0.35 (10.84%)

10:00
08/19/19
08/19
10:00
08/19/19
10:00
Hot Stocks
Unit Corp. rises 9.7% »

Unit Corp. is up 9.7%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

BE

Bloom Energy

$5.61

0.5 (9.78%)

10:00
08/19/19
08/19
10:00
08/19/19
10:00
Hot Stocks
Bloom Energy rises 9.9% »

Bloom Energy is up 9.9%,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ARMK

Aramark

$40.78

3.71 (10.01%)

10:00
08/19/19
08/19
10:00
08/19/19
10:00
Hot Stocks
Aramark rises 9.9% »

Aramark is up 9.9%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

QSR

Restaurant Brands

$74.89

0.36 (0.48%)

09:56
08/19/19
08/19
09:56
08/19/19
09:56
Recommendations
Restaurant Brands analyst commentary  »

SSS at Restaurant…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TGNA

Tegna

$15.70

0.62 (4.11%)

, APO

Apollo Global

$34.18

2.15 (6.71%)

09:56
08/19/19
08/19
09:56
08/19/19
09:56
Hot Stocks
Tegna jumps after report of Apollo deal interest »

Shares of Tegna (TGNA)…

TGNA

Tegna

$15.70

0.62 (4.11%)

APO

Apollo Global

$34.18

2.15 (6.71%)

NXST

Nexstar

$96.12

2.07 (2.20%)

TRCO

Tribune Media

$46.48

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Sep

  • 23

    Sep

  • 13

    Nov

EL

Estee Lauder

$193.74

14.48 (8.08%)

, DO

Diamond Offshore

$6.19

0.365 (6.27%)

09:55
08/19/19
08/19
09:55
08/19/19
09:55
Options
Early notable gainers among liquid option names on August 19th »

Notable gainers among…

EL

Estee Lauder

$193.74

14.48 (8.08%)

DO

Diamond Offshore

$6.19

0.365 (6.27%)

NVDA

Nvidia

$166.49

7.01 (4.40%)

WYNN

Wynn Resorts

$109.82

4.24 (4.02%)

TGNA

Tegna

$15.61

0.53 (3.51%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Aug

  • 19

    Aug

  • 20

    Aug

  • 27

    Aug

  • 05

    Sep

  • 09

    Sep

  • 23

    Sep

PCG

PG&E

$11.12

-3.18 (-22.24%)

09:52
08/19/19
08/19
09:52
08/19/19
09:52
Downgrade
PG&E rating change  »

Citi double downgrades…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.